IDEAYA Biosciences Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$140M
Industry:Pharma
Founded:2015
Lead Investor(s):N/A

Industry Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • IDEAYA Biosciences's estimated annual revenue is currently $12.9M per year.
  • IDEAYA Biosciences received $94.0M in venture funding in March 2018.
  • IDEAYA Biosciences's estimated revenue per employee is $201,000
  • IDEAYA Biosciences's total funding is $140M.

Employee Data

  • IDEAYA Biosciences has 64 Employees.
  • IDEAYA Biosciences grew their employee count by 10% last year.
  • IDEAYA Biosciences currently has 19 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$15.3M763%N/A-N/A
#2
N/A125N/AN/A-N/A
#3
$13.1M6523%N/A-N/A
#4
$53.1M264N/AN/A-N/A
#5
$10.1M504%N/A-N/A
#6
$13.5M6720%N/A-N/A
#7
$62.1M30910%N/A-N/A
#8
$22.5M1125%N/A-N/A
#9
N/A17N/AN/A-N/A
#10
$69.5M3462%N/A-N/A
Missing a competitor? Contribute!?
Submit

IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of personalized synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations and immuno-oncology therapies targeting the tumor microenvironment. Founded in 2015, IDEAYA's investors include 5AM Ventures (5AM), Canaan Partners (Canaan), Celgene, WuXi Healthcare Ventures (WuXi), Novartis Institute of Biomedical Research, and Alexandria Real Estate. The Company has assembled a world-class drug discovery team and Scientific Advisory Board (SAB) that is represented by a Nobel Laureate and three Members of the National Academy of Sciences. IDEAYA is located in South San Francisco and La Jolla, California.

keywords:Biotechnology,Healthcare,Pharmaceuticals

64

Number of Employees

$12.9M

Revenue (est)

19

Current Jobs

10%

Employee Growth %

$140M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

IDEAYA Biosciences News

24-Aug-19 - How Much Of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Do Institutions Own?

The big shareholder groups in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) have power over the company. Large companies usually have ...

12-Sep-19 - UPDATE: Baird Starts Ideaya Biosciences (IDYA) at Outperform

Baird analyst Madhu Kumar initiates coverage on Ideaya Biosciences (NASDAQ: IDYA) with a Outperform rating and a price target of $30.00.

12-Sep-19 - Here's Why IDEAYA Biosciences, Inc. (IDYA) Dropped -1.7%

In its most recent trading session, IDEAYA Biosciences, Inc. (IDYA) dropped by -1.7% – here is what that looked like (as of 2019-09-13): ...

IDEAYA Biosciences Funding

DateAmountRoundLead InvestorsReference
2016-05-04$46.0MAMultipleArticle
2018-03-16$94.0MBMultipleArticle

IDEAYA Biosciences Executive Hires

DateNameTitleReference
2018-03-14Julie Hambletonsenior vice president and chief medical officer, head of developmentArticle
2018-06-06Paul StoneSVP General Counsel, Head of OperationsArticle
2018-12-05Bao TruongVP/Head of Regulatory AffairsArticle